Skip to content
LLS Learning Management
  • Home
  • Courses for…
    • Physicians
    • Pharmacists
    • Pharmacy Technicians
    • Nurse Practitioners
    • Nurses
    • Social Workers
    • Archived Education
  • Other LLS Courses
  • Login

Myelodysplastic Syndromes (MDS): Diagnosis, Treatment and Side Effects Management

Home > Course > Myelodysplastic Syndromes (MDS): Diagnosis, Treatment and Side Effects Management

Myelodysplastic Syndromes (MDS): Diagnosis, Treatment and Side Effects Management

February 11, 2020 | By admin
0

Instructions for Credit —This activity is accredited for 1.0 continuing education credit for nurse practitioners, nurses, and social workers. Participants must attend the free webinar in its entirety, submit the online evaluation form  and complete and submit the online post-test with a passing score of 70% to earn credit. Once submitted, the certificate will be automatically generated as a PDF online. 

Please retain a copy of the certificate for your records.  For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc. at (609) 333-1693 or ndane@mlicme.org.

You must be enrolled to complete this activity for credit, however, you are not required to enroll simply to view the presentation.  

X

Please Complete Form

Accreditation and Disclosure Information

Target Audience — Nurse practitioners, nurses and oncology social workers  involved in the care of patients with myelodysplastic syndromes (MDS).

Course Content Level for Social Workers — Intermediate and Advanced

Format: Non-interactive recorded webinar

Learning Objectives — At the conclusion of this program, participants will be able to:
• Describe the various types and subtypes of MDS
• Identify tests used to diagnose disease and monitor treatment of MDS
• Explain the overarching goals of treatment for the types of MDS
• Explain approved and emerging treatment options for MDS, including stem cell transplantation, and the role of clinical trials 
• Describe the roles of the pharmacist, the nurse and the social worker in treating patients with MDS

Provider — This activity is provided by The Leukemia & Lymphoma Society.

Continuing Education for Nurse Practitioners, Nurses, and Social Workers

Nurse Practitioner Credit Designation

This activity is approved for  1.0 contact hour of continuing education (which includes .75 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20064277. This activity was planned in accordance with AANP Accreditation Standards and Policies.

 

Registered Nursing Designation 

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hours through the California Board of Registered Nursing.

Social Worker Designation 

The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. LLS maintains responsibility for this course. ACE provider approval period: 12/10/2020-12/10/2023. Social workers completing this course receive 1.0  continuing education credits.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for this program. Social workers will receive 1.0 CE clinical contact hours for this activity.

To view system requirements please go to https://llsce.org/system-requirements

For questions, grievances, or assistance with special needs (physical, etc.) please contact us at ProfEducation@LLS.org.

Disclosure of Conflicts of Interest — All faculty participating in continuing education activities by The Leukemia & Lymphoma Society are expected to disclose to activity participants any significant financial interest or other relationships with the manufacturer(s) of any commercial product(s) discussed in their presentations. The faculty are also expected to disclose any unlabeled or investigational uses of any product(s) discussed in their presentations.

Faculty Disclosures

Sangmin Lee, MD, Consulting fees from: AstraZeneca and Helsinn.

Peter Campbell, PharmD, BCOP, has no financial disclosures. 

Ayelet Nelson, RN, LMSW, ANP-BC, has no financial disclosures.

Content/Peer Reviewer Disclosure

Rookmini Singh, MSN, has no financial disclosures. 

Disclaimer –Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Estimated time to complete activity: 1.0 hours
Date of initial release: May 20, 2020
Expiration of: June 30, 2021
Speakers
Sangmin Lee, MD
Assistant Professor of Medicine
Weill Cornell Medical College 
Assistant Attending Physician
New York-Presbyterian Hospital
New York, NY

Sangmin Lee, MD, is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the NewYork-Presbyterian Hospital.

After obtaining a BA/MS as a Vagelos Scholar in Molecular Life Sciences at the University of Pennsylvania in 2003, Dr. Lee received his MD from the University of Miami in 2007.  Following his internal medicine residency at the University of Alabama at Birmingham, he completed his fellowship in hematology and oncology at the New York Presbyterian Hospital/Columbia University Medical Center from 2010-2013 where he focused on epigenetics of myelodysplastic syndromes (MDS) under Drs. Azra Raza and Benjamin Tycko.   In July 2013, Dr. Lee was recruited to serve in the Leukemia Program in the Division of Hematology & Medical Oncology.  At Weill Cornell, he has served as an Edward P. Evans Fellow in the multi-institutional MDS Clinical Research Consortium, focusing on development of clinical and translational research programs in MDS, as well as other hematologic malignancies.  He is currently the principal investigator on clinical trials investigating new therapeutic approaches in elderly AML patients, and is an investigator on a number of clinical trials for MDS, AML, and other myeloproliferative neoplams.  He is the principal investigator for translational studies focusing on characterization of mutational and epigenetic profiling of MDS and AML, in collaboration with scientists at Weill Cornell Medicine.

Dr. Lee has publications in the Clinical Cancer Research, and Journal of Blood Medicine, among others.  He is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research.


Peter Campbell, PharmD, BCOP
Clinical Pharmacy Manager
Hematology/Oncology
Columbia University Irving Medical Center
New York, NY

Peter Campbell, PharmD, BCOP, is a Clinical Pharmacy Manager at Columbia University Irving Medical Center in New York, New York. Dr. Campbell is a Board-Certified Oncology Pharmacist, and his area of specialized clinical practice is in acute and chronic leukemias, with a primary practice site of the inpatient setting. Dr. Campbell is also the Program Director for the PGY2 oncology pharmacy residency at New York-Presbyterian Hospital.

Dr. Campbell graduated from St. John’s University College of Pharmacy and Allied Health Professions in Queens, New York. He then completed a pharmacy practice residency followed by an oncology pharmacy specialty residency at New York-Presbyterian Hospital.


Ayelet Nelson, MSW, ANP-BC
Leukemia Outpatient Nurse Practitioner
Weill Cornell Medicine
New York, NY

Ayelet Nelson, MSW, ANP-BC, is a Leukemia Outpatient Nurse Practitioner at Weill Cornell Medicine in New York, New York, where she monitors and treats patients with hematologic malignancies utilizing both standard treatments as well as innovative treatments administered as part of clinical trials. Ms. Nelson earned her Masters of Social Work at the New York University Silver School of Social Work in New York, New York, and continued her education by completing the Adult Nurse Practitioner Master’s Program at the Boston College Connell School of Nursing in Chestnut Hill, Massachusetts. She is passionate about working with each patient as an individual to address his or her unique needs throughout the journey of a cancer diagnosis while providing compassionate care. She has also helped to initiate a support group for young adult patients with leukemia.

Resources

Resources for HCPs

Online & In-person free CME & CE courses: www.LLS.org/CE

Treating Blood Cancers podcasts: www.LLS.org/HCPpodcast

Clinical Trials and Research

  • Clinical Trials: Learn more about clinical trials: LLS.org/ClinicalTrials
  • Research: Focused on finding cures, driving research in areas of unmet medical need, and bridging the gap between academic discovery & drug development: LLS.org/Research

Advocacy dedicated to removing barriers to care: www.LLS.org/Advocacy

Resources for Patients

MDS Specific Resources – www.LLS.org/MDS

Free Information Booklets:  www.LLS.org/Booklets

Telephone/Web Education Programs:  www.LLS.org/Programs

Videos: www.LLS.org/Educationvideos

Podcasts: www.LLS.org/LLS-podcast

Support Resources : www.LLS.org/Support

  • Financial Assistance
    • Co-Pay
    • Travel Assistance
    • Referral to Medication Access programs
  • Information Resource Center
  • LLS Chapters
  • LLS Community (social media platform)
  • Patti Robinson Kaufman First Connection Program (peer-to-peer)
  • One-On-One Nutrition Consultations (PearlPoint)

Information Resource Specialists: www.LLS.org/IRC

Assist through treatment, financial & social challenges, and give accurate treatment and support information. HCPs can also order free materials to distribute to patients.

Clinical Trial Support Center:  www.LLS.org/CTSC

Patients & caregivers work one-on-one with an LLS Clinical Trial Nurse Navigator who will help find clinical trials and personally assist throughout the clinical trial process, providing an additional resource to the HCP team

  • Phone: (800) 955-4572, M-F, 9 am to 9 pm ET
  • Email: infocenter@LLS.org

Live chat: www.LLS.org/InformationSpecialists

If you have any questions, please contact us at  ProfEducation@LLS.org or call our Information Resource staff at 800-955-4572.

Course Content

MDS Presentation
Post-Activity Assessment [K20004MDS]
Evaluation and Application for Credit [K20004MDS]

Course Progress

0% Complete
0/2 Steps

Course Navigation

Course Home
MDS Presentation
Post-Activity Assessment [K20004MDS]
Evaluation and Application for Credit [K20004MDS]

Participant Type

2020 The Leukemia & Lymphoma Society
Login
Accessing this course requires a login, please enter your credentials below!

Forgot Password?
Lost Your Password?
Register
Don't have an account? Register one!
Register an Account

Registration confirmation will be emailed to you.